Printer Friendly

Global Blood Processing Supplies And Equipment Industry.

NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, March 16, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Blood Processing Supplies And Equipment Industry

http://www.reportlinker.com/p087335/Global-Blood-Processing-Supplies-And-Equipment-Industry.html

This report analyzes the worldwide markets for Blood Processing Supplies and Equipment in US$ Million by the following product segments: Blood Administration Sets, Blood Bank Freezers, Blood Bank Refrigerators, Blood Cell Processors, Blood Cell Washer Bags, Blood Collection Needles, Blood Collection & Micro Collector, Blood Collection Tube Adapter, Blood Donor Sets, Blood Filters, Blood Grouping blood grouping
n.
The process of identifying an individual's blood group by serologic testing of a sample of blood. Also called blood typing.
 Analyzers, Blood Lancets, Blood Sample Mailers, Blood Sampling Kits, Blood Tube Mixes, Blood Warming Coils/Pouches, Cleaning Solutions, Donor Blood (Blood Bank) Mix, Blood Grouping Reagents, Coagulation Reagents, Hematology Reagents, Hematology Stains, Control Plasmas, Hematocrit Hematocrit Definition

The hematocrit measures how much space in the blood is occupied by red blood cells. It is useful when evaluating a person for anemia.
Purpose

Blood is made up of red and white blood cells, and plasma.
 Centrifuges, Microscopic Slides, Sedimentation Tubes, Slide Stainers, Specimen Labels, Test Tube Racks, and Vials. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 128 companies including many key and niche players such as Beckman Coulter, Inc., Becton, Dickinson and Company, CaridianBCT, Inc., Fenwal Inc., Fresenius Kabi AG, Haemonetics Corp, Immucor Inc., Pall Corporation, and Terumo Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL URL
 in full Uniform Resource Locator

Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program.
 research and reported select online sources.

BLOOD PROCESSING SUPPLIES AND EQUIPMENT MCP-3506

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level Reporting Level

A level of ownership of a specific futures position wherein the holders exceed the stated amounts and are required by the CFTC to submit daily reports.

Also known as reporting limit.
 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

Blood Administration Sets 4

Blood Bank Freezers 4

Blood Bank Refrigerators 5

Blood Cell Processors 5

Blood Cell Washer Bags 5

Blood Collection Needles 5

Blood Collection and Micro Collectors 5

Blood Collection Tube Adapters 6

Blood Donor Sets 6

Blood Filters 6

Blood Grouping Analyzers 6

Blood Lancets 7

Blood Sample Mailers 7

Blood Sampling Kits 7

Blood Warming Coils/Pouches 7

Blood Grouping Reagents 7

Coagulation Reagents 7

Hematology Reagents 7

Hematology Stains 7

Control Plasmas 8

Hematocrit Centrifuges 8

Microscopic Slides 8

Sedimentation Tubes 8

Slide Stainer 8

Specimen Labels 8

Test Tube Racks 8

Vials 8

2. INDUSTRY OVERVIEW 9

Regional Perspective 9

Product Segment Perspective 9

3. MARKET DRIVERS 10

Growth Propellers 10

Other major Growth Drivers 10

4. MARKET LEADERS 11

Table 1: Leading Players in the Global Blood Bank Apheresis apheresis (əfĕr`əsĭs), or hemapheresis (hē'məfĕr`əsĭs), any procedure in which blood is drawn from a donor or patient and a component (platelets, plasma, or white blood  

Market (2006 & 2007): Market Share Breakdown of Value Sales

for Caridian BCT BCT Brigade Combat Team
BCT Basic Combat Training
BCT Best Conventional Pollutant Control Technology (EPA)
BCT Business Cards Tomorrow
BCT Banque Centrale de Tunisie (Central Bank of Tunisia) 
, Haemonetics, Baxter/Fenwal, and Others

(includes corresponding Graph/Chart) 11

Table 2: Leading Players in the Global Therapeutic Apheresis therapeutic apheresis A form of exchange transfusion in which blood is removed from a Pt and fluids returned to the general circulation: 1. Plasma is replaced–plasmapheresis with a volume of albumin or a crystalloid solution. 2.  

Market (2006 & 2007): Market Share Breakdown of Value Sales

for Caridian BCT, Fresenius, Haemonetics, Baxter/ Fenwal, and

Others (includes corresponding Graph/Chart) 12

List of Leading Players in the Worldwide Blood Processing

Supplies and Equipment Market 12

5. BLOOD COMPONENTS & DERIVATIVES 13

Red Blood Cells (RBCs) 13

White Blood Cells White blood cells
A group of several cell types that occur in the bloodstream and are essential for a properly functioning immune system.

Mentioned in: Abscess Incision & Drainage, Bone Marrow Transplantation, Complement Deficiencies
 (WBCs) 13

Platelets 13

Ionic Composition of Blood 14

Types of Blood 14

General Facts about Blood 15

General Uses of Blood 15

Blood - Global Facts 15

6. BLOOD PRODUCTS AND SERVICES - INDUSTRY STRUCTURE 16

Blood Collection Market Overview 16

Blood Squeeze Gets Tighter 16

Collection and Supply of Transfusable Products: Core Component

of Blood Products & Services Industry 16

Factors Driving Demand for Source Plasma 17

Blood Products Derived from Plasma 17

7. BLOOD ANALYSIS 18

Blood Analysis Equipment: Significant Changes in Type and

Manner of Deployment 18

i-Stat Develops Revolutionary Method of Blood Analysis 18

Automated Analyzers for Blood Analysis 18

8. LANDMARKS OF TRANSFUSION MEDICINE HISTORY 19

9. BLOOD BANKING 25

Blood Banks 25

Blood Collection and Processing 25

History of Blood Processing 25

Blood Collection Process 26

Blood Processing 26

Auto Transfusion 27

Blood Typing blood typing

Classification of blood by inherited antigens associated with erythrocytes (red blood cells). The ABO blood-group system and Rh blood-group system are among those most commonly considered.
 Techniques 28

ABO/Rh Testing 28

Continuous Flow Techniques 29

Cuvette-Based Techniques 29

Re-Suspension Technique 29

Groupamatic Instruments 30

Micro Plate Instruments 30

Streaming Technique 30

Solid-Phase Technique 31

Procedures for Blood Storage and Usage 31

Cost of Blood 31

Blood Grouping 31

Tests for Groups A, B, AB, O and Rh factors 32

Blood Screening 32

Antibody Screening 32

Infectious Disease Infectious disease

A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions.
 Testing 32

Apheresis 33

10. WORLDWIDE BLOOD PROCESSING SUPPLIES AND EQUIPMENT MARKET -

AN OVERVIEW 34

Growth in Medical Device Market Continues Amidst Global Recession 34

Product Segment Perspective 34

Blood Administration Sets 34

Straight Type Blood Administration Sets 34

Y Type Blood/Solution Administration Sets 35

Blood Component Recipient Sets 35

Blood Bank Freezers 35

Blood Bank Refrigerators 35

Blood Cell Processors 35

Blood Cell Washer Bags 36

Blood Collection Needles 36

Blood Collection and Micro Collectors 37

Blood Collection Tube Adapters 37

Blood Donor Sets 37

Blood Filters 37

Micropore micropore,
n 1. microscopic pores created by enamel etching in order to increase sealant adhesion.
n 2. an organelle in certain protozoa that develops at the site of a damaged membrane.
 Blood Filters 38

Blood Filtration Process 38

Leukocyte leukocyte (l`kəsīt'): see blood.
leukocyte
 or white blood cell or white corpuscle
 Depleting Filters Market Gains Momentum in Early

1990s 38

Blood Grouping Analyzers 39

Purchase Considerations for Blood Grouping Systems 40

Blood Lancets 41

Blood Sample Mailers 41

Blood Sampling Kits 41

Blood Tube Mixes 41

Blood Warming Coils/Pouches 41

Cleaning Solutions 41

Donor Blood (Blood Bank) Mixer 42

Blood Grouping Reagents 42

Coagulation Reagents 42

Hematology Reagents 42

Hematology Stains 43

Control Plasmas 43

Hematocrit Centrifuges 43

Microscopic Slides 43

Sedimentation Tubes 44

Slide Stainer 44

Specimen Labels 44

Test Tube Racks 44

Vials 44

11. SELECT COMPANY SPECIFIC PRODUCT PROFILES 45

Haemonetics' Products 45

Cell Save Autologous autologous /au·tol·o·gous/ (aw-tol´ah-gus) related to self; belonging to the same organism.

au·tol·o·gous
adj.
1.
 Blood Recovery System 45

OrthoPAT System 45

PCS (1) (Personal Communications Services) Refers to wireless services that emerged after the U.S. government auctioned commercial licenses in 1994 and 1995. This radio spectrum in the 1.  45

Cell Saver Plus 45

Cell Saver 3 Plus 45

Cell Saver 4 46

Cell Saver 5 46

HaemoLite 3 46

Caridian's Products 46

OrbiSac System(TM) 46

COBE COBE: see infrared astronomy.  Spectra(TM) Apheresis System 46

Immucor's Products 47

ROSYS Plato 47

DIAS PLUS 47

ThermoGenesis's Products 47

BioArchive System 47

The DAC(TM) System 47

ThermoLine (TM) Freezing and Thawing Systems 47

Freezing Systems 47

Thawing Systems 48

BD Vacutainer Push Button Blood Collection Set from Becton,

Dickinson and Company 48

12. CONCERNS FACING THE BLOOD INDUSTRY 49

Recession Hits North American North American

named after North America.


North American blastomycosis
see North American blastomycosis.

North American cattle tick
see boophilusannulatus.
 Blood Services Sector 49

Mixed Outcomes for Blood Banks in Recession 49

Novel Strategies to Recruitment Emerge During Recession 49

Industry Grappling with Blood Safety & Availability Issues 49

Synthetic Substitutes to Meet Demand-Supply Gap in Blood 50

Changes in Blood Collection Procedures to Overcome Blood

Shortage Problems 50

Hazards Involved in Blood Donations 51

Blood Transfusion blood transfusion, transfer of blood from one person to another, or from one animal to another of the same species. Transfusions are performed to replace a substantial loss of blood and as supportive treatment in certain diseases and blood disorders.  Risks 51

Infectious Agents Transmitted by Blood Transfusions 51

Human Immunodeficiency Virus human immunodeficiency virus
n.
HIV.


Human immunodeficiency virus (HIV)
A transmissible retrovirus that causes AIDS in humans.
 (HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. ) 51

Human T Lymphotropic Virus I, -II (HTLV-I, -II) 52

Cytomegalovirus cytomegalovirus (sī'təmĕg'əlōvī`rəs), member of the herpesvirus family that can cause serious complications in persons with weakened immune systems.  (CMV CMV cytomegalovirus.

CMV
abbr.
1. controlled mechanical ventilation

2. cytomegalovirus


Cytomegalovirus (CMV) 
) 52

Parasitic Infections 52

Malaria 52

Babesiosis babesiosis (bəbē'bēō`sĭs), tick-borne disease caused by a protozoan of the genus Babesia. Babesiosis most commonly affects domestic and wild animals and can be a serious problem in cattle.  52

Toxoplasmosis Toxoplasmosis Definition

Toxoplasmosis is an infectious disease caused by the one-celled protozoan parasite Toxoplasma gondii. Although most individuals do not experience any symptoms, the disease can be very serious, and even fatal, in
 52

Chagas Disease Cha·gas disease or Cha·gas-Cruz disease
n.
See South American trypanosomiasis.
 53

Lyme Disease Lyme disease, a nonfatal bacterial infection that causes symptoms ranging from fever and headache to a painful swelling of the joints. The first American case of Lyme's characteristic rash was documented in 1970 and the disease was first identified in a cluster at  53

Creutzfeldt-Jakob Disease Creutzfeldt-Jakob disease: see prion.
Creutzfeldt-Jakob disease
 or CJD

Rare fatal disease of the central nervous system. It destroys brain tissue, making it spongy and causing progressive loss of mental functioning and motor control.
 53

Viral Hepatitis viral hepatitis
n.
Any of various forms of hepatitis caused by a virus.


viral hepatitis,
n an inflammatory condition of the liver, caused by the hepatitis viruses: A, B, C, delta, E, F, G, or H.
 53

Background 53

Hepatitis A Virus Noun 1. hepatitis A virus - the virus causing hepatitis A
enterovirus - any of a group of picornaviruses that infect the gastrointestinal tract and can spread to other areas (especially the nervous system)
 (HAV HAV hepatitis A virus.

HAV
abbr.
hepatitis A virus


HAV Hepatitis A virus, see there
) 54

Hepatitis B Hepatitis B Definition

Hepatitis B is a potentially serious form of liver inflammation due to infection by the hepatitis B virus (HBV). It occurs in both rapidly developing (acute) and long-lasting (chronic) forms, and is one of the most common chronic
 Virus (HBV HBV hepatitis B virus.

HBV
abbr.
hepatitis B virus
) 54

Hepatitis C Virus
This page is for the virus. For the disease, see Hepatitis C.
The Hepatitis C virus (HCV) is a small (50 nm in size), enveloped, single-stranded, positive sense RNA virus in the family Flaviviridae.
 (HCV HCV
abbr.
hepatitis C virus


HCV 1 Hepatitis C virus, see there 2. Human coronavirus. See Coronavirus.
) 54

Hepatitis G Hepatitis G Definition

Hepatitis G is a newly discovered form of liver inflammation caused by hepatitis G virus (HGV), a distant relative of the hepatitis C virus.
 Virus (HGV HGV (in Britain, formerly) heavy goods vehicle

HGV (Brit) n abbr (Hist) (= heavy goods vehicle) → Lkw m 
) 54

Other Hepatitis Virii 55

Blood Family: Hepatitis Viruses 55

Blood Family: Retroviruses 55

Blood Family: Herpes Viruses 55

Blood Family: Parvoviruses 55

Blood Family: Spirochetes 56

Blood Family: Parasites 56

13. KEY MARKET TRENDS 57

Automation Tapping into Blood Market 57

Blood Conservation: Best Anti-AIDS Measure 57

Blood Decontamination decontamination /de·con·tam·i·na·tion/ (de?kon-tam-i-na´shun) the freeing of a person or object of some contaminating substance, e.g., war gas, radioactive material, etc.

de·con·tam·i·na·tion
n.
: Improves Blood Safety & Availability 58

Development of New Techniques to Ensure Safer Blood Supply 58

Pooled Testing: Economical Alternative for HIV Tests 58

Out-of-Hospital Transfusions: An Emerging Phenomenon 58

Out-of-Hours Blood Banking at Satellite Hospitals 59

Haemonetics Pioneers Automated Technology in Blood Processing 59

Blood Centers Receive Approval to Shift to Haemonetics'

Automated Equipment 59

Penetration of Automated Equipment in the Plasma Market 60

Automated Blood Processing Systems in Open Heart Surgeries 60

Automated Systems in Cancer 60

The Red Blood Cell red blood cell: see blood.  Collection Opportunity 61

Robots in Blood Banking 61

Hematology Instruments and Reagents Market Elicits Rosy Future 61

Lancets - The Most Preferred Blood Collection Device 62

EU Passes New Regulations 62

14. AUTOLOGOUS BLOOD TRANSFUSIONS VIS-A-VIS ALLOGENIC allogenic /al·lo·gen·ic/ (-jen´ik) allogeneic.
allogenic,
adj from individuals of the same species. Tissue transplanted from one person to another is said to be allogenic.
 BLOOD

TRANSFUSIONS 63

Donation Prior to Surgery 63

Hemodilution (Blood Dilution) 63

Intraoperative Blood Collection 64

Post Operative Blood Collection 64

Autologous Transfusions: Minimizing Risk of Blood- Borne Diseases 64

15. DISTRIBUTION CHANNELS 65

16. PRODUCT LAUNCHES 66

CBR (1) (Computer-Based Reference) Reference materials accessible by computer in order to help people do their jobs quicker. For example, this database on disk!

(2) (Constant Bit Rate) A uniform transmission rate.
 Systems Introduces New Stem Cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 Collection System 66

Pall Introduces New Advanced Blood Filter 66

BASi Unveils Culex Culex /Cu·lex/ (ku´leks) a genus of mosquitoes found throughout the world, many species of which are vectors of disease-producing organisms.

Cu·lex
n.
 ABC and Culex-L Automated Blood

Collection Solutions 66

QIAGEN and Biomatrica Launch QIAsafe DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 Blood Products 67

Poly Medicure Unveils Insulin Syringes and Blood Tubes 67

CellaVision Introduces DM 1200 Analyzer 67

CaridianBCT Rolls Out Atreus 3C Protocol 68

BD Diagnostics Introduces BD BACTEC(TM) FX Blood Culture System 68

Beckman Coulter Unveils UniCel DxH 800 Coulter CAS 69

RTS (Request To Send) An RS-232 signal sent from the transmitting station to the receiving station requesting permission to transmit. Contrast with CTS.

1. (operating system) RTS - run-time system.
2.
 Life Science Unveils Cutting-Edge ABF System 69

17. PRODUCT LAUNCHES IN THE RECENT PAST - A PERSPECTIVE BUILDER 71

Haemonetics Introduces Cymbal cymbal

Percussion instrument consisting of a circular metal plate that is struck with a drumstick or two such plates that are struck together. They were used, often ritually, in Assyria, Israel (from c.
, a Novel Portable Blood

Collecting System 71

BD Introduces BD Venflon Pro Safety IV Catheter 71

Arkray Launches Puncture Device & Needle for Blood Collection 71

JP To Launch Novel Products 71

Sysmex Introduces XS Series Automated Hematology Analyzer 72

Palco Labs to Introduce Several New Products 72

Haemonetics Unveils SmartSuction Solo Suction System for

Surgical Usage 72

BD Diagnostics Debuts BD Vacutainer Blood Collecting Tube in

Africa 73

ARKRAY Rolls Out Naturalet Device Set 73

5D(TM) Information Unleashes New Software for Efficient Blood

Collection 73

ALYX Component Collection System from Baxter 74

Gambro Unveils OrbiSac 74

TCP (1) (Transmission Control Protocol) The reliable transport protocol within the TCP/IP protocol suite. TCP ensures that all data arrive accurately and 100% intact at the other end.  Launches Transit Packaging Solution for Blood Banks 74

Immucor Launches Galileo in Europe 74

Terumo Penpol Ltd (TPL 1. TPL - Table Producing Language. "The Bureau of Labor Statistics Table Producing Language (TPL)", R.C. Mendelssohn, Proc ACM Annual Conf (1974).
2. TPL - Fleming Nielson. A concurrent functional language.
3.
), India Unveils Terumo Automatic

Component Extractor (T-ACE) 74

Haemotech Unveils Two New Systems for Blood Collection and

Management 75

18. RECENT INDUSTRY ACTIVITY 76

Guangzhou Instruments Obtains FDA Clearance for New Serum Tube 76

Cytomedix Signs Deal to Acquire Sorin's Angel System and

activAT Kit 76

Sekisui Chemical to Combine Chinese Medical Subsidiaries 77

BD Diagnostics Receives FDA Approval for BD Vacutainer Rapid

Serum Tube 77

Aurora to Acquire HLTH's Porex Corporation 77

Sysmex Secures FDA Approval for XE-2100D AHA 78

Fenwal to Establish JV with Golden Meditech for Blood-related

Technologies 78

Haemonetics Takes Over SEBRA SEBRA System for Etterbehandling av Rapporter  Blood Collection and Processing

Assets 79

UK Biobank Selects RTS' Automated Systems 79

NHSBT Deploys PK7300 Automatic Blood Grouping Solution 79

Hemo Bioscience Inks Distribution Agreement with ARC for Blood

Grouping Reagents 80

Haemonetics Snaps Up Neoteric ne·o·ter·ic  
adj.
Of recent origin; modern.



[Late Latin netericus, from Greek ne
 Technology 80

Shandong Taibang Divests Stake in Xi'an Huitian Blood Products 81

Haemonetics Acquires Altivation Software 81

Asahi Kasei Medical to Sign Agreement with TechniKrom 81

BioE Secures 510(k) FDA Approval for PrepaCyte-CB 81

BCT Japan to Change Name to CaridianBCT 82

Escalon Medical Acquires Biocode Hycel's Hematology Business 82

American Red Cross and CaridianBCT Enter into Agreement 83

Gambro BCT Changes Official Name to CaridianBCT 83

Terumo and Hettich Enter into Global Pact for New Blood

Processing System 83

19. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER 84

Haemonetics Acquires Haemoscope's Hemostasis hemostasis /he·mo·sta·sis/ (he?mo-sta´sis) (he-mos´tah-sis)
1. the arrest of bleeding by the physiological properties of vasoconstriction and coagulation or by surgical means.

2.
 Analyzer Business 84

Rheologics Technologies Purchases Cardiodyne Electronics 84

ThermoGenesis thermogenesis /ther·mo·gen·e·sis/ (-jen´e-sis) the production of heat, especially within the animal body.thermogenet´icthermogen´ic

ther·mo·gen·e·sis
n.
 Makes 510(k) Appeal to FDA 84

ThermoGenesis To Deliver Technology To SCP (1) (Service Control Point) A node in an SS7 telephone network that provides an interface to databases, which may reside within the SCP computer or in other computers.  for Research 84

Haemonetics Acquires Infonale 85

ViaCell Integrates Automation into Closed Blood Processing System 85

HTL-Strefa Wins 12 Million Contract 85

Biosafe Receives US FDA 510(k) Clearance for SEPAX 85

HMD See head mounted display.  To Expand Production Capacity 85

Quotient BioResearch bi·o·re·search  
n.
Research in the biological sciences.
 Acquires Alba Bioscience 86

Fresenius Kabi to Acquire Kyorin's Blood Volume Replacement

Operations 86

Haemonetics Acquires Assets of IDM (1) See identity management.

(2) (Integrated Device Manufacturer) A company that performs every step of the chip-making process, including design, manufacture, test and packaging. Examples of IDMs are Intel, AMD, Motorola, IBM, TI and Lucent.
 86

Baxter Divests Transfusion Therapies Business 87

Immucor's Galileo Echo Receives FDA Clearance for Marketing 87

ThermoGenesis Submits Application to US FDA for New

AutoXpress(TM) System 87

ProMetic Enters Blood-Filter License Pact with MacoPharma 88

Cryobanks' Licenses Cord Blood Processing Systems to CIIPL 88

Haemonetics Enters into Agreement with American Red Cross 88

Haemonetics Secures Multi-Year Contract from Canadian Blood

Services 89

Pall Secures Multi-Year Contract from National Blood Service 89

Cerus Enters into Agreement with Baxter Subsidiaries for

INTERCEPT Rights 89

ThermoGenesis Inks Contract with Cord Blood Registry 89

Biotest Applies for FDA Approval for Manual Blood Bank Reagents 90

Epocal Secures FDA Marketing Approval for EPOC A 32-bit operating system for handheld devices from Symbian Ltd., London, (www.symbian.com). Used in Psion and other handheld computers, it supports Java applications, e-mail, fax, infrared exchange, data synchronization with PCs and includes a suite of PIM and productivity applications.  90

Pall and VIAC VIAC Vermont Institute for Artisan Cheese  Obtain US FDA Approval for Cord Blood Collection

Bag 90

FMC See fixed mobile convergence.  Purchases RCG RCG Responsible Conduct of Gambling
RCG Revolutionary Communist Group (Northern Ireland)
RCG Raiffeisen Central Genossenschaft (German: Raiffeisen Cooperative)
RCG Race, Class and Gender
 91

Thermo Electron Takes Over Kendro Laboratory Products 91

Plasvacc Acquires Veterinary Dynamics 91

PRDT PRDT Power Rangers Dino Thunder (cartoon)
PRDT Pathogen Removal and Diagnostic Technologies Inc. (ProMetic and the American Red Cross joint venture to minimize the risk of Mad Cow Disease) 
 in Alliance with MacroPharma 91

Haemonetics Corporation Strikes a Deal with ZLB ZLB Zero Length Body
ZLB Zero Length Bit
 Plasma Services 92

Pall Enters into an Agreement with Green Cross 92

Consorta Extends Deal with SAI 92

Cerus Restructures Collaboration with Baxter 92

Sysmex America to Directly Supply Reagents and Controls 92

Haemonetics Corporation Takes Over Bloodless Surgery Station

Product Line 93

CorCell Merges with VITA 34 93

Haemonetics Corporation to Collaborate with Arryx, Inc 93

Pall Corporation Enters into an Agreement with Haemonetics 93

Beckman Coulter Strikes a Deal with Premier 93

Haemonetics Corporation Renews Agreement with American Red Cross 94

THERMOGENESIS Bags Order from Deva Medical 94

CSL (Computerese as a Second Language) Said of people who love to speak high-tech words even though they often use them erroneously. See TLA.

1. CSL - Computer Structure Language. A computer hardware description language, written in BCPL.
 Acquires Blood Plasma Unit of Aventis SA 94

Golden Meditech Bags Approval for ABRS ABRS Australian Biological Resources Study
ABRS Association of British Riding Schools (UK)
ABRS acute bacterial rhinosinusitis
ABRS Automated Book Request System
ABRS Asian Business Readership Survey
ABRS air bag restraint system
 94

Beckman Acquires SNP SNP Scottish National Party

Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily
 Genotyping Instruments and Other Assets

from Orchid 94

Pall's Pre-Donation, Blood Sample Diversion Pouch Receives FDA

Clearance 94

BD's The BD IMAGN(TM) System Receives FDA Clearance 95

Pall Corp Acquires Whatman Hemasure 95

Haemonetics Corp. Acquires Fifth Dimension Information Systems 95

Baxter International Acquires Rights to Epoetin Omega 95

Baxter International Earns FDA Clearance for Baxter's Alyx system 95

Haemonetics Corp. Acquires Plastic Bottle Operations of Alpha

Therapeutic 96

Whatman Acquires HemaSure Inc 96

HSCA Accords with Sigma Diagnostics 96

Baxter Installs New Production Facility in Neuchatel, Switzerland 96

Baxter International Shuts Down Two Blood Filter Manufacturing

Plants 96

Akzo Nobel Divests Organon or·ga·non or or·ga·num
n. pl. or·ga·nons or or·ga·nums or or·ga·na
1. An organ.

2. A set of principles for use in scientific investigation.



organon

pl. organa [Gr.] organ.
 Teknika 96

20. TECHNOLOGICAL DEVELOPMENTS 97

Pall Corp Develops Filter to Eliminate Abnormal Prion prion (prī`ŏn), infectious agent thought to cause a group of diseases known as

prion diseases or transmissible spongiform encephalopathies.
 Proteins 97

Haemonetics Corporation Unveils Improved Red Cell Collection

Technology 97

MSIAs Developed for Profiling Apolipoproteins 97

Study on Factors Related to HIV Infection Among First- time

Blood Donors in Zimbabwe 97

New Approach to Leukemia Treatment 98

ELISA ELISA (e-li´sah) Enzyme-Linked Immuno-Sorbent Assay; any enzyme immunoassay using an enzyme-labeled immunoreactant and an immunosorbent.

ELISA
n.
 Established as One of the Best Tests to Screen Blood

Donors for Chagas Disease 98

ANH ANH Anhang (German: Appendix; used in designating Beethoven's music)
ANH A New Hope
ANH A New Hope (aka Star Wars Episode 4)
ANH Alliance for Natural Health
 Proves more Economical than PAD in Cases of Radical

Prostatectomy 98

Biopure Develops the HBOC-201 RBC RBC red blood cell.

RBC or rbc
abbr.
red blood cell


RBC,
n See red blood cell count.


RBC

red blood cells; red blood (cell) count (see blood count).
 Replacement Solution 98

Exclusion of Additional Unexpected RBC Antibodies Facilitated

by Computer Program 99

21. FOCUS ON SELECT GLOBAL PLAYERS 100

Beckman Coulter Inc. (USA) 100

Becton, Dickinson and Company (USA) 100

CaridianBCT, Inc.(USA) 101

Fenwal Inc. (USA) 101

Fresenius Kabi AG (Germany) 101

Haemonetics Corp (USA) 102

Immucor Inc. (USA) 102

Pall Corp. (USA) 103

Terumo Corp. (Japan) 103

22. GLOBAL MARKET PERSPECTIVE 104

Table 3: World Recent Past, Current & Future Market Analysis

for Blood Processing Supplies and Equipment by Geographic

Region - US, Canada, Japan, Europe, Asia- Pacific (excluding

Japan), Latin America and Rest of World Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) 104

Table 4: World Historic Review for Blood Processing Supplies

and Equipment by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America, and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 105

Table 5: World 11-Year Perspective for Blood Processing

Supplies and Equipment by Geographic Region - Percentage

Breakdown of Dollar Sales for US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 106

Table 6: World Recent Past, Current & Future Market Analysis

for Blood Administration Sets by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 107

Table 7: World Historic Review for Blood Administration Sets

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 108

Table 8: World 11-Year Perspective for Blood Administration

Sets by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 109

Table 9: World Recent Past, Current & Future Market Analysis

for Blood Bank Freezers by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 110

Table 10: World Historic Review for Blood Bank Freezers by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 111

Table 11: World 11-Year Perspective for Blood Bank Freezers by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 112

Table 12: World Recent Past, Current & Future Market Analysis

for Blood Bank Refrigerators by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 113

Table 13: World Historic Review for Blood Bank Refrigerators

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 114

Table 14: World 11-Year Perspective for Blood Bank

Refrigerators by Geographic Region - Percentage Breakdown of

Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 115

Table 15: World Recent Past, Current & Future Market Analysis

for Blood Cell Processors by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 116

Table 16: World Historic Review for Blood Cell Processors by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 117

Table 17: World 11-Year Perspective for Blood Cell Processors

by Geographic Region - Percentage Breakdown of Dollar Sales

for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 118

Table 18: World Recent Past, Current & Future Market Analysis

for Blood Cell Washer Bags by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 119

Table 19: World Historic Review for Blood Cell Washer Bags by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 120

Table 20: World 11-Year Perspective for Blood Cell Washer Bags

by Geographic Region - Percentage Breakdown of Dollar Sales

for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 121

Table 21: World Recent Past, Current & Future Market Analysis

for Blood Collection Needles by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 122

Table 22: World Historic Review for Blood Collection Needles

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 123

Table 23: World 11-Year Perspective for Blood Collection

Needles by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 124

Table 24: World Recent Past, Current & Future Market Analysis

for Blood Collection & Micro Collectors by Geographic Region -

US, Canada, Japan, Europe, Asia- Pacific (excluding Japan),

Latin America and Rest of World Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 125

Table 25: World Historic Review for Blood Collection & Micro

Collectors by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 126

Table 26: World 11-Year Perspective for Blood Collection &

Micro Collectors by Geographic Region - Percentage Breakdown

of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 127

Table 27: World Recent Past, Current & Future Market Analysis

for Blood Collection Tube Adapters by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 128

Table 28: World Historic Review for Blood Collection Tube

Adapters by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 129

Table 29: World 11-Year Perspective for Blood Collection Tube

Adapters by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 130

Table 30: World Recent Past, Current & Future Market Analysis

for Blood Donor Sets by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 131

Table 31: World Historic Review for Blood Donor Sets by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 132

Table 32: World 11-Year Perspective for Blood Donor Sets by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 133

Table 33: World Recent Past, Current & Future Market Analysis

for Blood Filters by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 134

Table 34: World Historic Review for Blood Filters by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 135

Table 35: World 11-Year Perspective for Blood Filters by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 136

Table 36: World Recent Past, Current & Future Market Analysis

for Blood Grouping Analyzers by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 137

Table 37: World Historic Review for Blood Grouping Analyzers

by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 138

Table 38: World 11-Year Perspective for Blood Grouping

Analyzers by Geographic Region - Percentage Breakdown of

Dollar Sales for US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 139

Table 39: World Recent Past, Current & Future Market Analysis

for Blood Lancets by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 140

Table 40: World Historic Review for Blood Lancets by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 141

Table 41: World 11-Year Perspective for Blood Lancets by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 142

Table 42: World Recent Past, Current & Future Market Analysis

for Blood Sample Mailers by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 143

Table 43: World Historic Review for Blood Sample Mailers by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 144

Table 44: World 11-Year Perspective for Blood Sample Mailers

by Geographic Region - Percentage Breakdown of Dollar Sales

for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 145

Table 45: World Recent Past, Current & Future Market Analysis

for Blood Sampling Kits by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 146

Table 46: World Historic Review for Blood Sampling Kits by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 147

Table 47: World 11-Year Perspective for Blood Sampling Kits by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 148

Table 48: World Recent Past, Current & Future Market Analysis

for Blood Tube Mixes by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 149

Table 49: World Historic Review for Blood Tube Mixes by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 150

Table 50: World 11-Year Perspective for Blood Tube Mixes by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 151

Table 51: World Recent Past, Current & Future Market Analysis

for Blood Warming Coils/Pouches by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 152

Table 52: World Historic Review for Blood Warming

Coils/Pouches by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America, and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 153

Table 53: World 11-Year Perspective for Blood Warming Coils/

Pouches by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 154

Table 54: World Recent Past, Current & Future Market Analysis

for Cleaning Solutions by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 155

Table 55: World Historic Review for Cleaning Solutions by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 156

Table 56: World 11-Year Perspective for Cleaning Solutions by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 157

Table 57: World Recent Past, Current & Future Market Analysis

for Donor Blood (Blood Bank) Mix by Geographic Region - US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 158

Table 58: World Historic Review for Donor Blood (Blood Bank)

Mix by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America, and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 159

Table 59: World 11-Year Perspective for Donor Blood (Blood

Bank) Mix by Geographic Region - Percentage Breakdown of

Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 160

Table 60: World Recent Past, Current & Future Market Analysis

for Blood Grouping Reagents by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 161

Table 61: World Historic Review for Blood Grouping Reagents by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 162

Table 62: World 11-Year Perspective for Blood Grouping

Reagents by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 163

Table 63: World Recent Past, Current & Future Market Analysis

for Coagulation Reagents by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 164

Table 64: World Historic Review for Coagulation Reagents by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 165

Table 65: World 11-Year Perspective for Coagulation Reagents

by Geographic Region - Percentage Breakdown of Dollar Sales

for US, Canada, Japan, Europe, Asia- Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 166

Table 66: World Recent Past, Current & Future Market Analysis

for Hematology Reagents by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 167

Table 67: World Historic Review for Hematology Reagents by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 168

Table 68: World 11-Year Perspective for Hematology Reagents by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 169

Table 69: World Recent Past, Current & Future Market Analysis

for Hematology Stains by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 170

Table 70: World Historic Review for Hematology Stains by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 171

Table 71: World 11-Year Perspective for Hematology Stains by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 172

Table 72: World Recent Past, Current & Future Market Analysis

for Control Plasmas by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 173

Table 73: World Historic Review for Control Plasmas by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 174

Table 74: World 11-Year Perspective for Control Plasmas by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 175

Table 75: World Recent Past, Current & Future Market Analysis

for Hematocrit Centrifuges by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 176

Table 76: World Historic Review for Hematocrit Centrifuges by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 177

Table 77: World 11-Year Perspective for Hematocrit Centrifuges

by Geographic Region - Percentage Breakdown of Dollar Sales

for US, Canada, Japan, Europe, Asia- Pacific (excluding

Japan), Latin America and Rest of World Markets for Years

2005, 2010 & 2015 (includes corresponding Graph/Chart) 178

Table 78: World Recent Past, Current & Future Market Analysis

for Microscopic Slides by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 179

Table 79: World Historic Review for Microscopic Slides by

Geographic Region - US, Canada, Japan, Europe, Asia- Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 180

Table 80: World 11-Year Perspective for Microscopic Slides by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 181

Table 81: World Recent Past, Current & Future Market Analysis

for Sedimentation Tubes by Geographic Region - US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 182

Table 82: World Historic Review for Sedimentation Tubes by

Geographic Region - US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 183

Table 83: World 11-Year Perspective for Sedimentation Tubes by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 184

Table 84: World Recent Past, Current & Future Market Analysis

for Slide Stainers by Geographic Region - US, Canada, Japan,

Europe, Asia-Pacific

To order this report:

Blood Supply, Tissue Banking and Transplantation Industry: Global Blood Processing Supplies And Equipment Industry

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
COPYRIGHT 2011 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:90ASI
Date:Mar 16, 2011
Words:8075
Previous Article:MV Sales and Leasing Awarded HGACBuy National Contract.
Next Article:/C O R R E C T I O N -- Audi of America, Inc./.
Topics:

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters